Evidence map›Paper›PMID 25234641›Full record

ArticleBrain : a journal of neurology2014

Glutamatergic neuron-targeted loss of LGI1 epilepsy gene results in seizures.

Morgane Boillot, Clément Huneau, Elise Marsan, Katia Lehongre, Vincent Navarro, Saeko Ishida, Béatrice Dufresnois, Ekim Ozkaynak, Jérôme Garrigue, Richard Miles and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. LGI1 Autoantibodies Enhance Synaptic Transmission by Presynaptic KNeurology(R) neuroimmunology & neuroinflammation · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Neuropsychiatric Disorders Due to Limbic Encephalitis: Immunologic Aspect.International journal of molecular sciences · 2020
    Review
  9. Article
  10. Review
  11. Antagonizing IncreasedThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  12. Frontiers in neurology · 2019
    Review
  13. Celecoxib Ameliorates Seizure Susceptibility in Autosomal Dominant Lateral Temporal Epilepsy.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  14. Article
  15. LGI1 tunes intrinsic excitability by regulating the density of axonal Kv1 channels.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Morgane Boillot1 INSERM, U 1127, F-75013, Paris, France 2 CNRS, UMR 7225, F-75013, Paris, France 3 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, ICM, F-75013 Paris, France 4 Institut du Cerveau et de la Moelle épinière (ICM), F-75013, Paris, France.
Clément Huneau5 Université de Rennes 1, LTSI, F-35000, Rennes, France 6 INSERM, U1099, F-35000, Rennes, France.
Elise Marsan1 INSERM, U 1127, F-75013, Paris, France 2 CNRS, UMR 7225, F-75013, Paris, France 3 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, ICM, F-75013 Paris, France 4 Institut du Cerveau et de la Moelle épinière (ICM), F-75013, Paris, France.
Katia Lehongre1 INSERM, U 1127, F-75013, Paris, France 2 CNRS, UMR 7225, F-75013, Paris, France 3 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, ICM, F-75013 Paris, France 4 Institut du Cerveau et de la Moelle épinière (ICM), F-75013, Paris, France.
Vincent Navarro1 INSERM, U 1127, F-75013, Paris, France 2 CNRS, UMR 7225, F-75013, Paris, France 3 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, ICM, F-75013 Paris, France 4 Institut du Cerveau et de la Moelle épinière (ICM), F-75013, Paris, France 7 AP-HP, Hôpital de la Pitié-Salpêtrière, Epilepsy Unit, F-75013, Paris, France.
Saeko Ishida1 INSERM, U 1127, F-75013, Paris, France 2 CNRS, UMR 7225, F-75013, Paris, France 3 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, ICM, F-75013 Paris, France 4 Institut du Cerveau et de la Moelle épinière (ICM), F-75013, Paris, France.
Béatrice Dufresnois1 INSERM, U 1127, F-75013, Paris, France 2 CNRS, UMR 7225, F-75013, Paris, France 3 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, ICM, F-75013 Paris, France 4 Institut du Cerveau et de la Moelle épinière (ICM), F-75013, Paris, France.
Ekim Ozkaynak8 Departments of Neurology and Pathology, Beth Israel Deaconess Medical Centre and Harvard Medical School, Boston, Massachusetts 02215, USA.
Jérôme Garrigue1 INSERM, U 1127, F-75013, Paris, France 2 CNRS, UMR 7225, F-75013, Paris, France 3 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, ICM, F-75013 Paris, France 4 Institut du Cerveau et de la Moelle épinière (ICM), F-75013, Paris, France.
Richard Miles1 INSERM, U 1127, F-75013, Paris, France 2 CNRS, UMR 7225, F-75013, Paris, France 3 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, ICM, F-75013 Paris, France 4 Institut du Cerveau et de la Moelle épinière (ICM), F-75013, Paris, France.
Benoit Martin5 Université de Rennes 1, LTSI, F-35000, Rennes, France 6 INSERM, U1099, F-35000, Rennes, France.
Eric Leguern1 INSERM, U 1127, F-75013, Paris, France 2 CNRS, UMR 7225, F-75013, Paris, France 3 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, ICM, F-75013 Paris, France 4 Institut du Cerveau et de la Moelle épinière (ICM), F-75013, Paris, France 9 AP-HP, Hôpital de la Pitié-Salpêtrière, Département de Génétique et de Cytogénétique, F-75013, Paris, France.
Matthew P Anderson8 Departments of Neurology and Pathology, Beth Israel Deaconess Medical Centre and Harvard Medical School, Boston, Massachusetts 02215, USA.
Stéphanie Baulac1 INSERM, U 1127, F-75013, Paris, France 2 CNRS, UMR 7225, F-75013, Paris, France 3 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, ICM, F-75013 Paris, France 4 Institut du Cerveau et de la Moelle épinière (ICM), F-75013, Paris, France stephanie.baulac@upmc.fr.
Centre National de la Recherche Scientifique · FRInserm · FRHarvard University · USInstitut du Cerveau · FRPitié-Salpêtrière Hospital · FRSorbonne Université · FRUniversité de Rennes · FR

Funding

SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI POMEROY, SCOTT LOREN · 1985 to 2015
$26.2M
Neurobiological Mechanism of 15q11-13 Duplication Autism Spectrum DisorderR01NS081916 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ANDERSON, MATTHEW P · 2012 to 2016
$1.9M
Role of LGI1 in Autosomal Dominant Lateral Temporal Lobe EpilepsyR01NS057444 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ANDERSON, MATTHEW P · 2008 to 2011
$1.3M
Neurobiology of Aggression Co-morbidity in Mouse Model of Idic15 AutismR21MH100868 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ANDERSON, MATTHEW P · 2013 to 2014
$479k
NICHD NIH HHS P30 HD018655NIMH NIH HHS R21 MH100868NINDS NIH HHS R01NS057444NINDS NIH HHS R01 NS081916NINDS NIH HHS R01NS081916
6 · The paper itself

Abstract

Leucin-rich, glioma inactivated 1 (LGI1) is a secreted protein linked to human seizures of both genetic and autoimmune aetiology. Mutations in the LGI1 gene are responsible for autosomal dominant temporal lobe epilepsy with auditory features, whereas LGI1 autoantibodies are involved in limbic encephalitis, an acquired epileptic disorder associated with cognitive impairment. We and others previously reported that Lgi1-deficient mice have early-onset spontaneous seizures leading to premature death at 2-3 weeks of age. Yet, where and when Lgi1 deficiency causes epilepsy remains unknown. To address these questions, we generated Lgi1 conditional knockout (cKO) mice using a set of universal Cre-driver mouse lines. Selective deletion of Lgi1 was achieved in glutamatergic pyramidal neurons during embryonic (Emx1-Lgi1cKO) or late postnatal (CaMKIIα-Lgi1cKO) developmental stages, or in gamma amino butyric acidergic (GABAergic) parvalbumin interneurons (PV-Lgi1cKO). Emx1-Lgi1cKO mice displayed early-onset and lethal seizures, whereas CaMKIIα-Lgi1cKO mice presented late-onset occasional seizures associated with variable reduced lifespan. In contrast, neither spontaneous seizures nor increased seizure susceptibility to convulsant were observed when Lgi1 was deleted in parvalbumin interneurons. Together, these data showed that LGI1 depletion restricted to pyramidal cells is sufficient to generate seizures, whereas seizure thresholds were unchanged after depletion in gamma amino butyric acidergic parvalbumin interneurons. We suggest that LGI1 secreted from excitatory neurons, but not parvalbumin inhibitory neurons, makes a major contribution to the pathogenesis of LGI1-related epilepsies. Our data further indicate that LGI1 is required from embryogenesis to adulthood to achieve proper circuit functioning.

Indexed as

Age FactorsAnimalsAnimals, NewbornBrainElectroencephalographyEmbryo, MammalianGABAergic NeuronsInterneuronsIntracellular Signaling Peptides and ProteinsMiceMice, KnockoutNeuronsProteinsPyramidal CellsSeizuresIntracellular Signaling Peptides and ProteinsLgi1 protein, mouseProteinsADEAFconditional knockoutepilepsygeneticsLGI1

Identifiers

PMID25234641
PMCPMC4208469
OpenAlexW1965669328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.